The return of the Scarlet Pimpernel: cobalamin in inflammation II — cobalamins can both selectively promote all three nitric oxide synthases (NOS), particularly iNOS and eNOS, and, as needed, selectively inhibit iNOS and nNOS

References

• Wheatley C. A Scarlet Pimpernel for the resolution of inflammation? The role of supra‐therapeutic doses of cobalamin, in the treatment of systemic inflammatory response syndrome (SIRS), sepsis, severe sepsis, and septic or traumatic shock. Med Hypotheses 2006; 67: 124–42
   PubMedGoogle Scholar
• Wheatley C. A unified theory of the causes of monoclonal gammopathy of unknown significance (MGUS) and multiple myeloma, with a consequent treatment proposal for long‐term control and possible cure. J Orthomol Med 2002; 17: 7–16
   Google Scholar
• Olesen H., Andersen M. P., Amris A. Serum vitamin B12 binding capacity in patients with anaemia. Scand J Haematol 1968; 5: 235–40
   PubMedGoogle Scholar
• Seetharam B., Li N. Transcobalamin II and its cell surface receptors. Vitam Horm 2000; 59: 337–66
   PubMedGoogle Scholar
• Ghosh K., Mohanty D., Rana K. S., et al. Plasma transcobalamins in haematological disorders. Folia Haematol Int Mag Klin Morphol Blutforsch 1986; 113: 766–75
   PubMedGoogle Scholar
• Christensen P. A., Brynskov J., Gimsing P., Petersen J. Vitamin B12 binding proteins (transcobalamin and haptocorrin) in serum and synovial fluid of patients with rheumatoid arthritis and traumatic synovitis. Scand J Rheumatol 1983; 12: 268–72
   PubMed Web of Science ®Google Scholar
• Lasser U., Kierat L., Grob P., et al. Transcobalamin II, a serum protein reflecting autoimmune disease activity, its plasma dynamics, and the relationship to established serum parameters in systemic lupus erythematosus. Clin Immunol Immunopathol 1985; 36: 345–57
   PubMedGoogle Scholar
• Rachmilewitz D., Ligumsky M., Rachmilewitz B., et al. Transcobalamin II level in peripheral blood monocytes – a biochemical marker in inflammatory diseases of the bowel. Gastroenterology 1980; 78: 43–6
   PubMedGoogle Scholar
• Nexø E., Olesen H. Intrinsic factor, transcobalamin, and haptocorrin. B12, biochemistry and medicine., D Dolphin. Wiley‐Interscience, New York 1982; 57–85
   Google Scholar
• Macdonald C., Bessent R., Adams J. Transcobalamin‐binding capacities in vitamin B12‐related diseases. Am J Clin Pathol 1981; 75: 677–83
   PubMedGoogle Scholar
• Carmel R., Eisenberg L. Serum B12 and transcobalamin abnormalities in people with cancer. Cancer 1977; 40: 1348–53
   PubMed Web of Science ®Google Scholar
• Carmel R., Hollander H. Extreme elevations of transcobalamin II levels in multiple myeloma and other disorders. Blood 1978; 51: 1057–63
   PubMed Web of Science ®Google Scholar
• Rachmilewitz B., Sulkes A., Rachmilewitz M., Fuks Z. Serum transcobalamin II levels in breast carcinoma patients. Isr J Med Sci 1981; 17: 874–8
   PubMedGoogle Scholar
• Baeuerle P., Baltimore D. Meeting review. NFκB ten years after. Cell 1996; 87: 13–20
   PubMed Web of Science ®Google Scholar
• Kleinwort H., Schwarz P. M., Förstermann U. Regulation of the expression of inducible nitric oxide synthase. J Biol Chem 2003; 384: 1343–64
   Google Scholar
• Wagener F. A. D. T. G., Volk H‐D., Willis D. Different faces of the heme–heme oxygenase system in inflammation. Pharmacol Rev 2003; 55: 551–71
   PubMed Web of Science ®Google Scholar
• Wheatley C., Perretti M., D'Acquisto F., Sampaio A. L. F., et al. (in preparation). 2006
   Google Scholar
• Perretti M., Wheatley C., D'Acquisto F., Sampaio A. L. F., et al. (in preparation). 2007
   Google Scholar
• Griscavage J. M., Fukuto J. M., Komori Y., Ignarro L. J. Nitric oxide inhibits neuronal nitric oxide synthase by interacting with the heme prosthetic group. J Biol Chem 1994; 269((34))21644–9
   PubMedGoogle Scholar
• Albakri Q. A., Stuehr D. J. Intracellular assembly of inducible NO synthase is limited by nitric oxide – mediated changes in heme insertion and availability. J Biol Chem 1996; 271((10))5414–21
   PubMedGoogle Scholar
• Peng H‐B., Spiecker M., Liao J. K. Inducible nitric oxide: an autoregulatory feedback inhibitor of vascular inflammation. J Immunol 1998; 161: 1970–6
   PubMed Web of Science ®Google Scholar
• Mathews J. R., Botting C. H., Panico M., Morriss H. R., Hay R. T. Inhibition of NFκB binding by nitric oxide. Nucleic Acids Res 1996; 24: 2236–42
   PubMed Web of Science ®Google Scholar
• Markle H. V. Cobalamin. Crit Rev Clin Lab Sci 1996; 33: 247–56
   PubMed Web of Science ®Google Scholar
• Chemistry and biochemistry of B12., R Banerjee. Wiley Interscience, New York 1999; 1–921
   Google Scholar
• Nexø E. Cobalamin binding proteins. Vitamin B12 and B12 proteins, B Kräutler, D Arigoni, B. T Golding. Wiley, La Jolla 1998; 461–75
   Google Scholar
• Beck W. S. Biological and medical aspects of vitamin B12. B12, biochemistry and medicine., D Dolphin. Wiley‐Interscience, New York 1982; 1–30
   Google Scholar
• Seetharam B. Receptor‐mediated endocytosis of cobalamin (vitamin B12). Annu Rev Nutr 1999; 19: 173–95
   PubMed Web of Science ®Google Scholar
• Ostray F., Gams R. A. Cellular fluxes of vitamin B12. Blood 1997; 50: 877–88
   Google Scholar
• Moestrup S. K. Cellular surface receptors important for vitamin B12 nutrition. Vitamin B12 and B12 proteins., B Kräutler, D Arigoni, B. T Golding. Wiley, La Jolla 1998; 477–89
   Google Scholar
• Carmel R. The distribution of endogenous cobalamin among cobalamin‐binding proteins in the blood in normal and abnormal states. Am J Clin Nutr 1985; 41: 713–9
   PubMed Web of Science ®Google Scholar
• Zittoun J., Marquet J., Zittoun R. The intracellular content of the three transcobalamins at various stages of normal and leukaemic myeloid cell development. Br J Haematol 1975; 31: 299–310
   PubMedGoogle Scholar
• Herbert V. B12 deficiency in AIDS. J Am Med Assoc 1988; 260: 2837
   Google Scholar
• Carmel R., Eisenberg L. Serum B12 and transcobalamin abnormalities in people with cancer. Cancer 1977; 40: 1348–53
   PubMed Web of Science ®Google Scholar
• Lindenbaum J., Rosenberg I. H., Wilson P. W., et al. Prevalence of cobalamin deficiency in the Framingham elderly population. Am J Clin Nutr 1994; 60: 2–11
   PubMed Web of Science ®Google Scholar
• Alberti C., Brun‐Buisson C., Burchardi H., et al. Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med 2002; 28: 108–21
   PubMed Web of Science ®Google Scholar
• Brasch N. E., Hsu T., Doll K. M., Finke R. G. Synthesis and characterization of isolable thiolatocobalamin complexes relevant to coenzyme B12‐dependent ribonucleotide triphosphate reductase. J Inorg Biochem 1999; 76: 197–209
   PubMedGoogle Scholar
• Suto R. K., Brasch N. E., Anderson O. P., Finke R. G. Synthesis, characterization, solution stability and X‐ray crystal structure of the thiolatocobalamin γ‐glutamylcysteinylcobalamin, a dipeptide analog of glutathionylcobalamin: insights into the enhanced Co‐S bond stability of the natural product glutathionylcobalamin. Inorg Chem 2001; 40: 2686–92
   PubMed Web of Science ®Google Scholar
• Xia L., Cregan A. G., Berben L. A., Brasch N. E. Studies on the formation of glutathionylcobalamin: any free intracellular aquacobalamin is likely to be rapidly and irreversibly converted to glutathionylcobalamin. Inorg Chem 2004; 43: 6848–57
   PubMed Web of Science ®Google Scholar
• Dubnoff J. W. A cobalamin glutathione complex. Biochem Biophys Res Commun 1964; 16((5))484–8
   PubMedGoogle Scholar
• Adler N., Medwick T., Poznanski T. J. Reaction of hydroxocobalamin with thiols. J Am Chem Soc 1966; 88((21))5018–20
   Google Scholar
• Jacobsen D. W., Lee‐Denison C., Luce K., Green R. Glutathionylcobalamin (GSCbl) is found in cultured and ascites leukemia‐L1210 cells. Fed Proc 1987; 46: 1005
   Google Scholar
• Pezacka E., Green R., Jacobsen D. W. Glutathionylcobalamin as an intermediate in the formation of cobalamin coenzymes. Biochem Biophys Res Comm 1990; 169((2))443–50
   PubMedGoogle Scholar
• Kim J. H., Demaurex N., Grinstein S. Intracellular pH: measurement, manipulation and physiological regulation. Handbook of biological physics, W. N Koning, H. R Kaback, J. S Lolkema. Elsevier Science, Amsterdam 1996; 2: 447–72
   Google Scholar
• Luschinsky Drennan C., Huang S., Drummond J. T., Matthews R. G., Ludwig M. L. How a protein binds B12: a 3.0Å X‐ray structure of B12‐binding domains of methionine synthase. Science 1994; 266: 1669–74
   PubMedGoogle Scholar
• Mancia F., Keep N. H., Nakagawa A., et al. How coenzyme B12 radicals are generated: the crystal structure of methylmalonyl‐coenzyme A mutase at 2Å resolution. Structure 1996; 4((3))339–49
   PubMedGoogle Scholar
• Sirovatka J. M., Finke R. G. Coenzyme B12 chemical precedent studies: probing the role of the imidazole base‐on motif found in B12‐dependent methylmalonyl‐CoA mutase. J Am Chem Soc 1997; 119: 3057–67
   Google Scholar
• Poston J. M. β‐leucine and the β‐keto pathway of leucine metabolism. Adv Enzymol 1986; 58: 173–89
   PubMedGoogle Scholar
• Stabler S. P., Lindenbaum J., Allen R. H. Failure to detect β‐leucine in human blood or leucine 2, 3‐aminomutase in rat liver using capillary gas chromatography‐mass spectrometry. J Biol Chem 1988; 263((12))5581–8
   PubMedGoogle Scholar
• Metz J., Kelly A., Chapin Swett V., Waxman S., Herbert V. Deranged DNA synthesis by bone marrow from vitamin B12 deficient humans. Br J Haematol 1968; 14: 575–91
   PubMed Web of Science ®Google Scholar
• Mason J. B., Levesque T. Folate: effects on carcinogenesis and the potential for cancer chemoprevention. Oncology 1996; 10: 1727–43
   PubMedGoogle Scholar
• Beattie D. S. Bioenergetics and oxidative metabolism. Textbook of biochemistry, with clinical correlations, T. M Devlin. Wiley‐Liss, New York 2006; 531–80
   Google Scholar
• Parker J. N., Parker P. M. Vitamin B12, a medical dictionary, bibliography, and annotated research guide to Internet references. 2004; 1–344
   Google Scholar
• Riou B., Gérard J. L., Drieu la Rochelle C., et al. Hemodynamic effects of hydroxocobalamin in conscious dogs. Anaesthesia 1991; 74: 552–8
   Google Scholar
• Rajanayagam M. A. S., Li C. G., Rand M. J. Differential effects of hydroxocobalamin on NO‐mediated relaxations in rat aorta and anococcygeus muscle. Br J Pharmacol 1993; 108: 3–5
   PubMed Web of Science ®Google Scholar
• Greenberg S. S., Zie J., Zatarain J. M., et al. Hydroxocobalamin (vitamin B12) prevents and reverses endotoxin‐induced hypertension and mortality in rodents: role of nitric oxide. J Pharmacol Exp Ther 1995; 273: 257–65
   PubMed Web of Science ®Google Scholar
• Kruszyna R., Kruszyna H., Smith R. P., Thron C. D., Wilcox D. E. Nitrite conversion to nitric oxide in red cells and its stabilisation as a nitrosylated valency hybrid of hemoglobin. J Pharmacol Exp Ther 1987; 241: 307–13
   PubMedGoogle Scholar
• Rochelle L. G., Morana S. J., Kruszyna H., et al. Interactions between hydroxocobalamin and nitric oxide (NO): evidence for a redox reaction between NO and reduced cobalamin and reversible NO binding to oxidized cobalamin. J Pharmacol Exp Ther 1995; 275: 48–52
   PubMed Web of Science ®Google Scholar
• Brouwer M., Chamulitrat W., Ferruzzi G., Sauls D. L., Weinberg J. B. Nitric oxide interactions with cobalamins: biochemical and functional consequences. Blood 1996; 88((5))1857–64
   PubMedGoogle Scholar
• Zheng D., Yan L., Birke R. L. Electrochemical and spectral studies of the reactions of aquacobalamin with nitric oxide and nitrite ion. Inorg Chem 2003; 41: 2548–55
   Google Scholar
• Kruszyna H., Magyar J., Rochelle L. G. Spectroscopic studies of nitric oxide (NO) interactions with cobalamins: reaction of NO with superoxocobalamin(II) likely accounts for cobalamin reversal of the biological effects of NO. J Pharmacol Exp Ther 1998; 285: 665–71
   PubMed Web of Science ®Google Scholar
• Wolak M., Stochel G., Hamza M., Van Eldik R. Aquacobalamin (vitamin B12a) does not bind NO in aqueous solution. Nitrite impurities account for observed reaction. Inorg Chem 2000; 39: 2018–9
   PubMedGoogle Scholar
• Zheng D., Birke R. L. The reaction of nitric oxide with glutathionylcobalamin. J Am Chem Soc 2002; 124: 9066–7
   PubMedGoogle Scholar
• Danishpajooh I. O., Gudi T., Yongchang C., et al. Nitric oxide inhibits methionine synthase activity in vivo and disrupts carbon flow through the folate pathway. J Biol Chem 2001; 276((29))27296–303
   PubMedGoogle Scholar
• Stamler J. S., Singel D. J., Loscalzo J. Biochemistry of nitric oxide and its redox activated forms. Science 1992; 258: 1898–902
   PubMed Web of Science ®Google Scholar
• Bauer J., Morrison B. H., Grane R., et al. Effects of interferon β on transcobalamin II‐receptor expression and anti‐tumor activity of nitrosylcobalamin. J Natl Cancer Inst 2002; 94((13))1010–9
   PubMedGoogle Scholar
• Mushett C. W., Kelly K. L., Boxer G. E., et al. Antidotal efficacy of vitamin B12 (hydroxocobalamin) in experimental cyanide poisoning. Proc Soc Exp Biol Med 1952; 81: 234–7
   PubMed Web of Science ®Google Scholar
• Traina V. Vitamin B12 as an anti‐anaphylactic. Nature 1950; 166: 78–9
   PubMedGoogle Scholar
• Badyuzin I. S. The anti‐shock activity of large doses of cyanocobalamin. Byull Eksp Biol Med 1965; 60: 62–4
   Google Scholar
• Posner M. A., Rodkey F. L., Tobey R. E. Nitroprusside‐induced cyanide poisoning: antidotal effect of hydroxocobalamin. Anaesthesia 1976; 44: 330–5
   Google Scholar
• Mitrofanov V. G. The pathogenesis of traumatic shock and its complication with radiation sickness. 1959, [in Russian]
   Google Scholar
• Lazarev N. V., Vishniakov S. M. Problem of increasing resistance of the organism to operative trauma by medical means. Vestn Khir 1957; 79((11))19–23, [in Russian]
   PubMedGoogle Scholar
• Yacoub M., Faure H., Morena M., et al. L'intoxication cyanhydrique aiguë. Données actuelles sur le métabolisme du cyanure et le traitement par hydroxocobalamine. J Europ de Toxicol 1974; 7: 22–9
   Google Scholar
• Motin J., Bouletrean P., Rouzious J. M. Intoxication cyanhydrique grave traitée avec succès par hydroxocobalamine. J Med de Strasbourg 1970; I: 717–22
   Google Scholar
• Tassan H., Joyon D., Richard T., et al. Intoxication au cyanure de potassium traitée par l'hydroxocobalamine. Ann Fr Anesth Reanim 1990; 9: 383–5
   PubMed Web of Science ®Google Scholar
• Brouard A., Blaisot B., Bismuth C. Hydroxocobalamine in cyanide poisoning. J Toxicol Clin Exp 1987; 7: 155–68
   PubMedGoogle Scholar
• Hall A. H., Rumack B. H. Hydroxocobalamin/sodium thiosulfate as a cyanide antidote. J Emerg Med 1987; 5: 115–21
   PubMedGoogle Scholar
• Forsyth J. C., Mueller P. D., Becker C. E., et al. Hydroxocobalamin as a cyanide antidote: safety, efficacy and pharmacokinetics in heavily smoking normal volunteers. Clin Toxicol 1993; 31: 277–94
   Web of Science ®Google Scholar
• Wheatley C. A novel approach to the treatment of septic shock?. J Nutr Environ Med 2004; 14((1))56–7
   Google Scholar
• Nathan C. Points of control in inflammation. Nature, Inflammation 2002; 420: 846–52
   Google Scholar
• Henson P. M. Editorial: Get the balance right. Dampening inflammation. Nature Immunol 2005; 6: 1177–81
   PubMedGoogle Scholar
• MacMicking J., Xie Q., Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol 1997; 15: 323–50
   PubMed Web of Science ®Google Scholar
• Hamers M. N., Roos D. Oxidative stress in human neutrophilic granulocytes: host defence and self‐defence. Oxidative stress., H Sies. Academic Press, London 1985; 351–81
   Google Scholar
• Flohé L., Beckmann R., Giertz H., . Oxygen‐centered free radicals as mediators of inflammation. Oxidative stress., H Sies, et al. Academic Press, London 1985; 403–36
   Google Scholar
• Deora A. A., Lauder H. M. Role of nitric oxide and other radicals in signal transduction. Nitric oxide: biology and pathobiology., L. J Ignarro. Academic Press, San Diego 2000; 251–63
   Google Scholar
• Darley‐Usmar V. M., Patel R. P., O'Donnell V. B., Freeman B. A. Antioxidant actions of nitric oxide. Nitric oxide: biology and pathobiology., L. J Ignarro. Academic Press, San Diego 2000; 265–76
   Google Scholar
• Stamler J. S., Lamas S., Fang F. C. Meeting review. Nitrosylation: the prototypic redox‐based signaling mechanism. Cell 2001; 106: 675–83
   PubMed Web of Science ®Google Scholar
• Sies H. Oxidative stress: introductory remarks. Oxidative stress., H Sies. Academic Press, London 1985; 1–8
   Google Scholar
• Oxidative stress and the molecular biology of antioxidant defenses., J. G Scandalios. Cold Spring Harbour, New York 1997
   Google Scholar
• Wolin M. S., Mohazzab‐H K. M. Mediation of signal transduction by oxidants. Oxidative stress and the molecular biology of antioxidant defenses., J. G Scandalios. Cold Spring Harbour, New York 1997; 21–48
   Google Scholar
• Chance B., Sies H., Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol Rev 1979; 59: 527–605
   PubMed Web of Science ®Google Scholar
• Meister A. On the biochemistry of glutathione. Glutathione centennial, molecular perspectives and clinical implications., N Tamiguchi, T Higashi, Y Sakanoto, A Meister. Academic Press, New York 1989; 1–21
   Google Scholar
• Peunora N., Enikolopov G. Amplification of calcium‐induced gene transcription by nitric oxide in neuronal cells. Nature 1993; 364: 450–3
   PubMedGoogle Scholar
• Greenberg D. A. Bilirubin and the brain. Sci Med 2003; 9: 96
   Google Scholar
• Schwarz N. B. Carbohydrate metabolism II: special pathways and glycoconjugates. Textbook of biochemistry, with clinical correlations., T. M Devlin. Wiley‐Liss, New York 2006; 637–60
   Google Scholar
• Borovikova L. V., Lvanona S., Zhang M., et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000; 405: 458–62
   PubMed Web of Science ®Google Scholar
• Damazo A. S., Yona S., D'Acquisto F., Flower R. J., Oliani S. M., Perretti M. Critical protective role for Annexin I gene expression in the endotoxemic murine microcirculation. Am J Pathol 2005; 166: 1607–17
   PubMed Web of Science ®Google Scholar
• Endres S., Ghorbani R., Kelley V. E., et al. The effect of dietary supplementation with n‐3 polyunsaturated fatty acids on the synthesis of interleukin‐1 and tumor necrosis factor by mononuclear cells. New Engl J Med 1989; 320: 265–71
   PubMed Web of Science ®Google Scholar
• Serhan C. N., Gotlinger K., Hong S., et al. Anti‐inflammatory actions of neuroprotectin DI/protectin DI and its natural stereoisomers: assignments of dihydroxy‐containing docosatrienes. J Immunol 2006; 176: 1848–59
   PubMed Web of Science ®Google Scholar
• Serhan C. N., Clish C. B., Brannon J., et al. Novel functional sets of lipid‐derived mediators with anti‐inflammatory actions generated from omega‐3 fatty acids via cyclooxygenase 2–nonsteroidal antiinflammatory drugs and transcellular processing. J Exp Med 2000; 192: 1197–204
   PubMed Web of Science ®Google Scholar
• Ramstedt U., Janet N. G., Wigzell H., Serhan C. N., Samuelson B. Action of novel eicosanoids lipoxin A and B on human natural killer cell toxicity: effects on intracellular cAMP and target cell binding. J Immunol 1985; 135: 3434–8
   PubMed Web of Science ®Google Scholar
• Ajuebor M. N., Das A. M., Virag L., Flower R. J., Szabó C., Perretti M. Role of resident peritoneal macrophages and mast cells in chemokine production and neutrophil migration in acute inflammation: evidence for an inhibitory loop involving endogenous IL‐10. J Immunol 1999; 162: 1685–91
   PubMed Web of Science ®Google Scholar
• Wahl S. M. Regulation of tissue inflammation, repair, and fibrosis by transforming growth factor beta. Epidermal growth factors and cytokines., T. A Luger, T Schwarz. Marcel Dekker, New York 1994; 241–52
   Google Scholar
• Lawrence T., Gilroy D. W., Colville‐Nash P. R., Willoughby D. A. Possible new role for NFκB in the resolution of inflammation. Nature Med 2001; 7((12))1291–7
   PubMedGoogle Scholar
• Llesuy S., Evelson P., Gonzalez‐Flecha B., et al. Oxidative stress in muscle and liver of rats with septic syndrome. Free Radic Biol Med 1994; 16: 445–51
   PubMed Web of Science ®Google Scholar
• Poderoso J. J., Carreras M. C., Lisdero C., et al. Nitric oxide inhibits electron transfer and increases superoxide radical production in rat heart mitochondria and submitochondrial particles. Arch Biochem Biophys 1996; 328((1))85–92
   PubMedGoogle Scholar
• Ruetten H., Thiemermann C. Nitric oxide and septic shock. Nitric oxide: biology and pathobiology., L. J Ignarro. Academic Press, San Diego 2000; 747–57
   Google Scholar
• Vincent J. L., Zhang H., Szabo C., Preiser J. C. Effects of nitric oxide in septic shock. Am J Respir Crit Care Med 2000; 161: 1781–5
   PubMed Web of Science ®Google Scholar
• Evans T. J., Cohen J. Mediators: nitric oxide and other toxic oxygen species. Pathology of septic shock., E. T Rietschel, H Wagner. Springer, Berlin 1996; 189–208
   Google Scholar
• Schmidt H. W., Hofmann H., Schindler U., et al. No •NO from NO synthase. Proc Natl Acad Sci 1996; 93: 14492–7
   PubMed Web of Science ®Google Scholar
• Vallance P. Assessment of nitric oxide in humans. Nitric oxide: biology and pathobiology., L. J Ignarro. Academic Press, San Diego 2000; 923–4
   Google Scholar
• Fukuto J. M., Cho J. Y., Switzer C. H. The chemical properties of nitric oxide and related nitrogen oxides. Nitric oxide: biology and pathobiology., L. J Ignarro. Academic Press, San Diego 2000; 23–40
   Google Scholar
• Weinberg J. B., Lang T., Wilkinson W. E., Pisetsky D. S., St Clair W. E. Serum, urinary and salivary nitric oxide in rheumatoid arthritis: complexities of interpreting nitric oxide measures. Arthritis Res Ther 2006; 8: R140
   PubMedGoogle Scholar
• Coomes M. W. Amino acid metabolism. Textbook of biochemistry, with clinical correlations., T. M Devlin. Wiley‐Liss, New York 2006; 743–87
   Google Scholar
• Kaeseler Andersen S., Gjedsted J., Christiansen C., Tonnesen E. The roles of insulin and hyperglycemia in sepsis pathogenesis. J Leukocyte Biol 2004; 75: 413–21
   PubMedGoogle Scholar
• Kilbourn R. G., Jubran A., Gross S. S., et al. Reversal of endotoxin mediated shock by NG‐methyl‐l‐arginine, an inhibitor of nitric oxide synthesis. Biochem Biophys Res Commun 1990; 172: 1132–8
   PubMed Web of Science ®Google Scholar
• Florquin S., Amraoui Z., Dubois C., Decuyper J., Goldman M. The protective role of endogenously synthesized nitric oxide in staphylococcal enterotoxin B‐induced shock in mice. J Exp Med 1994; 180: 1153–8
   PubMed Web of Science ®Google Scholar
• Kamijo R., Harada H., Matsuyama M., et al. Requirement for transcription factor IRF‐1 in NO synthase induction in macrophages. Science 1994; 263: 1612–5
   PubMed Web of Science ®Google Scholar
• Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 1992; 6: 3051–64
   PubMed Web of Science ®Google Scholar
• Vodovotz Y., Kopp J. B., Takeguchi H., et al. Increased mortality, blunted production of nitric oxide, and increased production of TNF‐alpha in endotoxemic TGF‐beta1 transgenic mice. J Leukocyte Biol 1998; 63: 31–9
   PubMedGoogle Scholar
• Peracchi M., Bamonti Catena F., Pomati M., et al. Human cobalamin deficiency: alterations in serum tumour necrosis factor‐α and epidermal growth factor. Eur J Haematol 2001; 67: 123–7
   PubMed Web of Science ®Google Scholar
• Wang S., Wang W., Wesley R. A., Danner R. L. A Sp1 binding site of the TNFα promoter functions as a nitric oxide response element. J Biol Chem 1999; 274: 33190–3
   PubMedGoogle Scholar
• Pardali K., Kurisaki A., Moren A. Role of Smad proteins and transcription factor Sp1 in p21 (Waf1/Cip1) regulation of TGFβ. J Biol Chem 2000; 275: 29244–56
   PubMed Web of Science ®Google Scholar
• Merchant J. L., Shiotani A., Mortensen E. R., et al. Epidermal growth factor stimulation of the human gastrin promoter requires Sp1. J Biol Chem 1995; 270: 6314–9
   PubMedGoogle Scholar
• Reinhart K., Karzai W. Anti‐tumor necrosis factor therapy in sepsis: update on clinical trials and lessons learned. Crit Care Med 2001; 29: S121–5
   PubMed Web of Science ®Google Scholar
• Laubach V. E., Shesely E. G., Smithies O., Sherman P. A. Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide‐induced death. Proc Natl Acad Sci 1995; 92: 10688–92
   PubMed Web of Science ®Google Scholar
• MacMicking J. D., Nathan C., Hom G., et al. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 1995; 81: 641–50
   PubMed Web of Science ®Google Scholar
• McCaddon A., Regland B., Hudson P., Davies G. Functional vitamin B12 deficiency and Alzheimer disease. Neurology 2002; 58: 1395–9
   PubMed Web of Science ®Google Scholar
• Hobbs M. R., Udhayakumar V., Levesque M., et al. A new NOS2 promoter polymorphism associated with increased nitric oxide production and protection from severe malaria in Tanzanian and Kenyan children. Lancet 2002; 360: 1468–75
   PubMed Web of Science ®Google Scholar
• Nathan C. Natural resistance and nitric oxide. Cell 1995; 82: 873–6
   PubMedGoogle Scholar
• Force R. W., Nahata M. C. Effect of histamine H2‐receptor antagonists on vitamin B12 absorption. Ann Pharmacother 1992; 10: 1283–6
   Google Scholar
• Ruscin M. J., Page R. L., Valuck R. J. Vitamin B12 deficiency associated with histamine 2‐receptor antagonists and a proton‐pump inhibitor. Ann Pharmacother 2002; 36: 812–6
   PubMed Web of Science ®Google Scholar
• Katusic Z. S. Superoxide anion and endothelial regulation of arterial tone. Free Radic Biol Med 1996; 20: 443–8
   PubMed Web of Science ®Google Scholar
• Kinoshita H., Tsutsui M., Milstien S., Katusic Z. S. Tetrahydrobiopterin, nitric oxide and regulation of cerebral vascular tone. Prog Neurobiol 1997; 52: 295–302
   PubMedGoogle Scholar
• Mayer B., Hemmens B. Biosynthesis and action of nitric oxide in mammalian cells. Trends Biochem Sci 1997; 22: 477–81
   PubMed Web of Science ®Google Scholar
• Rusche K. M., Spiering M. M., Marletta M. A. Reactions catalyzed by tetrahydrobiopterin‐free nitric oxide synthase. Biochemistry 1998; 37: 15503–12
   PubMed Web of Science ®Google Scholar
• Alderton W. K., Cooper C. E., Knowles R. G. Nitric oxide synthases: structure, function, and inhibition. Biochem J 2001; 357: 593–615
   PubMed Web of Science ®Google Scholar
• Ma X. L., Gao F., Liu G‐L., et al. Opposite effects of nitric oxide and nitroxyl on postischemic myocardial injury. Proc Natl Acad Sci 1999; 96: 14617–22
   PubMed Web of Science ®Google Scholar
• Stamler J. S. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell 1994; 78: 931–6
   PubMed Web of Science ®Google Scholar
• Wolin M. S. Mechanisms through which reactive nitrogen and oxygen species interact with physiological signaling systems. Nitric oxide: biology and pathobiology., L. J Ignarro. Academic Press, San Diego 2000; 277–92
   Google Scholar
• Kong S‐K., Bin Yim M., Stadtman E. R., Boon Chock F. Peroxynitrite disables the tyrosine phosphorylation regulatory mechanism: lymphocyte‐specific tyrosine kinase fails to phosphorylate nitrated cdc2(6‐20) NH2 peptide. Proc Natl Acad Sci 1996; 93: 3377–82
   PubMed Web of Science ®Google Scholar
• Kleinert H., Boissel J. P., Schwarz P. M., Förstermann U. Regulation of the expression of nitric oxide synthase isoforms. Nitric oxide: biology and pathobiology., L. J Ignarro. Academic Press, San Diego 2000; 105–28
   Google Scholar
• Groves J. T., Wang C. C‐Y. Nitric oxide synthase: models and mechanisms. Curr Opin Chem Biol 2000; 4: 687–95
   PubMed Web of Science ®Google Scholar
• Moncada S. Cited in Stamler JS, Lamas S, Fang FC. Meeting review. Nitrosylation: the prototypic redox‐based signaling mechanism. Cell 2001; 106: 675–83
   PubMedGoogle Scholar
• Wang Y., Newton D. C., Robb G. B., et al. RNA diversity has profound effects on the translation of neuronal nitric oxide synthase. Proc Natl Acad Sci 1999; 96: 12150–5
   PubMed Web of Science ®Google Scholar
• Mannick J. B., Asano K., Izumi K., Kieff E., Stamler J. S. Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein–Barr virus reactivation. Cell 1994; 79: 1137–46
   PubMed Web of Science ®Google Scholar
• Casadei B., Sears C. E. Nitric oxide‐mediated regulation of cardiac contractility and stretch responses. Prog Biophys Mol Biol 2003; 82: 67–80
   PubMedGoogle Scholar
• Palamalai V., Darrow R. M., Organisciak D. T., Miyagi M. Light‐induced changes in protein nitration in photoreceptor rod outer segments. Mol Vis 2006; 12: 1543–51
   PubMedGoogle Scholar
• Koniaris L. G., McKillop L. A., Schwartz S. I., Zimmers T. A. Liver regeneration. J Am Coll Surg 2003; 197: 634–9
   PubMed Web of Science ®Google Scholar
• Guo F. H., De Raeve H. R., Stuehr D. J., et al. Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo. Proc Natl Acad Sci 1995; 92: 7809–13
   PubMed Web of Science ®Google Scholar
• Hoffman R. A., Zhang G., Nussler N. C., et al. Constitutive expression of inducible nitric oxide synthase in the mouse ileal mucosa. Am J Physiol 1997; 272: G383–92
   PubMedGoogle Scholar
• Gaston B., Reilly J., Drazen J. M., et al. Endogenous nitrogen oxides and bronchodilator s‐nitrosothiols in human airways. Proc Natl Acad Sci 1993; 90: 10957–61
   PubMed Web of Science ®Google Scholar
• Crane B. R., Arvai A. S., Gachui R., et al. The structure of nitric oxide synthase oxygenase domain and inhibitor complexes. Science 1997; 278: 425–31
   PubMed Web of Science ®Google Scholar
• Crane B. R., Arvai A. S., Ghosh D. K., et al. Structure of nitric oxide synthase oxygenase dimer with pterin and substrate. Science 1998; 279: 2121–6
   PubMed Web of Science ®Google Scholar
• Fischmann T. O., Hruza A., Niu X. D., et al. Structural characterization of nitric oxide synthase isoforms reveals striking active‐site conservation. Nat Struct Biol 1999; 6: 233–42
   PubMedGoogle Scholar
• Li H., Raman C. S., Glaser C. B., et al. Crystal structures of zinc‐free and ‐bound heme domain of human inducible nitric oxide synthase. Implications for dimer stability and comparison with endothelial nitric oxide synthase. J Biol Chem 1999; 274: 21276–84
   PubMedGoogle Scholar
• Raman C. S., Li H., Martasek P., Kral V., Masters B. S., Poulos T. L. Crystal structure of constitutive endothelial nitric oxide synthase: a paradigm for pterin function involving a novel metal center. Cell 1998; 95: 939–50
   PubMed Web of Science ®Google Scholar
• Tierney D. L., Huang H., Martasek P., et al. ENDOR studies of l‐arginine and N‐G‐hydroxyl‐l‐arginine bound to all three holo‐nitric oxide synthase isoenzymes. J Am Chem Soc 2000; 122: 5405–6
   Google Scholar
• Ganster R. W., Geller D. A. Molecular regulation of inducible nitric oxide synthase. Nitric oxide: biology and pathobiology., L. J Ignarro. Academic Press, San Diego 2000; 129–56
   Google Scholar
• Hobbs A. J., Fukuto J. M., Ignarro L. J. Formation of free nitric oxide from l‐arginine by nitric oxide synthase; direct enhancement of generation by superoxide dismutase. Proc Natl Acad Sci 1994; 91: 10992–6
   PubMed Web of Science ®Google Scholar
• Murphy M. E., Sies H. Reversible conversion of nitroxyl anion to nitric oxide by superoxide dismutase. Proc Natl Acad Sci 1991; 88: 10860–4
   PubMed Web of Science ®Google Scholar
• Miller R. T., Martasek P., Roman L. J. Involvement of the reductase domain of neuronal nitric oxide synthase in superoxide anion production. Biochemistry 1997; 36: 15277–84
   PubMedGoogle Scholar
• Xia Y., Zweier J. L. Direct measurement of nitric oxide generation from nitric oxide synthase. Proc Natl Acad Sci 1997; 94: 12705–10
   PubMed Web of Science ®Google Scholar
• Vasquez‐Vivar J., Hogg N., Martasek P., et al. Tetrahydrobiopterin‐dependent inhibition of superoxide generation from neuronal nitric oxide synthase. J Biol Chem 1999; 274: 26736–42
   PubMedGoogle Scholar
• Vasquez‐Vivar J., Kalyanaraman B., Martasek P., et al. Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc Natl Acad Sci 1998; 95: 9220–5
   PubMed Web of Science ®Google Scholar
• Rusche K. M., Spiering M. M., Marletta A. A. Reactions catalysed by tetrahydrobiopterin‐free nitric oxide synthase. Biochemistry 1998; 37: 15503–12
   PubMed Web of Science ®Google Scholar
• List B. M., Klosch B., Volker C., et al. Characterization of bovine endothelial nitric oxide synthase as a homodimer with down‐regulated uncoupled NADPH oxidase activity; tetrahydrobiopterin binding kinetics and role of haem in dimerization. Biochem J 1997; 323: 159–65
   PubMed Web of Science ®Google Scholar
• Stroes E., Hijmering M., Van Zandvoort M., et al. Origin of superoxide production by endothelial nitric oxide synthase. FEBS Lett 1998; 438: 161–4
   PubMed Web of Science ®Google Scholar
• Xia Y., Roman L. J., Masters B. S., Zweier J. L. Inducible nitric oxide synthase generates superoxide from the reductase domain. J Biol Chem 1998; 273: 22635–9
   PubMed Web of Science ®Google Scholar
• Beckman J. S., Beckman T. W., Chen J., Marshall P. A., Freeman B. A. Apparent hydroxyl radical production by peroxynitrite; implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci 1990; 87: 1620–4
   PubMed Web of Science ®Google Scholar
• Gross S., Levi R. Tetrahydrobiopterin synthesis. J Biol Chem 1992; 267: 25722–9
   PubMed Web of Science ®Google Scholar
• Cosentino F., Patton S., d'Uscio L. V., et al. Tetrahydrobiopterin alters superoxide and nitric oxide release in prehypertensive rats. J Clin Invest 1998; 101: 1530–7
   PubMed Web of Science ®Google Scholar
• Stroes E., Kastelein J., Cosentino F., et al. Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. J Clin Invest 1997; 99: 41–6
   PubMed Web of Science ®Google Scholar
• Wever R. M. F., van Dam T., van Rijn H. J. M., de Groot P. G., Rabeliak T. J. Tetrahydrobiopterin regulates superoxide and nitric oxide generation by recombinant endothelial nitric oxide synthesis. Biochem Biophys Res Comm 1997; 237: 340–4
   PubMed Web of Science ®Google Scholar
• Chen X., Reynolds E. R., Ranganayakulu G., O'Donnell J. M. A maternal product of the Punch locus of Drosophila melanogaster is required for precellular blastoderm nuclear division. J Cell Sci 1994; 107: 3501–13
   PubMedGoogle Scholar
• Gross S. S., Jones L. J., Hattori Y., Raman C. S. Tetrahydrobiopterin: an essential cofactor of nitric oxide synthase with an elusive role. Nitric oxide: biology and pathobiology., L. J Ignarro. Academic Press, San Diego 2000; 167–86
   Google Scholar
• Visconti M., Karmer P. Fluoresziende Stoffe aus Drosophila melanogaster. Helv Chim Acta 1957; 40: 986
   Google Scholar
• Cory G. J. Purine and pyrimidine nucleotide metabolism. Textbook of biochemistry, with clinical correlations., T. M Devlin. Wiley‐Liss, New York 2006; 790–822
   Google Scholar
• Zhuo S., Fan S., Kaufman S. Effects of depletion of intracellular tetrahydrobiopterin in murine erythro‐leukemia cells. Exp Cell Res 1996; 222: 163–70
   PubMedGoogle Scholar
• Werner‐Felmayer G., Goldferer G., Werner E. R., Gröbner P., Wachter H. Pteridine biosynthesis and nitric oxide synthase in Physarum polycephalum. Biochem J 1994; 304: 105–11
   PubMed Web of Science ®Google Scholar
• Wachter H., Fuchs D., Reibnegger G., Werner E. R. Neopterin as a marker for activation of cellular immunity: immunologic basis and clinical application. Adv Clin Chem 1989; 27: 81–141
   PubMed Web of Science ®Google Scholar
• Krehan A., Ansuini H., Böcher O., et al. Transcription factors, Ets‐1, NFκB, and Sp1 are major determinants of the promoter activity of the human protein kinase CK2α gene. J Biol Chem 2000; 275: 18327–36
   PubMed Web of Science ®Google Scholar
• Szabo C., Mitchell J. A., Thiemermann C., Vane J. R. Nitric oxide‐mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock. Br J Pharmacol 1993; 108((3))786–92
   PubMedGoogle Scholar
• Hoffer A. The effect of adrenochrome and adrenolutin on the behaviour of animals and the psychology of man. Int Rev Neurobiol 1962; 4: 307–71
   Google Scholar
• Hoffer A. Adrenochrome and blood plasma. Am J Psychiatr 1958; 114: 752–3
   PubMedGoogle Scholar
• Tracey K. J. The inflammatory reflex. Nature, Inflammation 2002; 420: 853–9
   Google Scholar
• Bolton C. F., Young G. B., Zochodne D. W. Neurological changes during severe sepsis. Current topics in intensive care., H Burchardii, G Dobb, J Biou, R. F Dellinger. WB Saunders, London 1994; 180–218
   Google Scholar
• Cohen J. The immunopathogenesis of sepsis. Nature, Inflammation 2002; 420: 885–9
   Google Scholar
• Scalabrino G., Carpo M., Bamonti F., et al. High tumor necrosis factor‐α levels in cerebrospinal fluid of cobalamin‐deficient patients. Ann Neurol 2004; 56: 886–90
   PubMedGoogle Scholar
• Brealey D., Brand M., Hargreaves I., et al. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 2002; 360: 219–23
   PubMed Web of Science ®Google Scholar
• Morris S. M. Regulation of arginine availability and its impact on NO synthesis. Nitric oxide: biology and pathobiology., L. J Ignarro. Academic Press, San Diego 2000; 187–97
   Google Scholar
• Deitch E. A., Specian R. D., Berg R. D. Endotoxin‐induced bacterial translocation and mucosal permeability: role of xanthine oxidase, complement activation and macrophageal products. Crit Care Med 1991; 19: 785–91
   PubMed Web of Science ®Google Scholar
• Awad W. M. Iron and heme metabolism. Textbook of biochemistry, with clinical correlations., T. M Devlin. Wiley‐Liss, New York 2006; 824–47
   Google Scholar
• Wang P., Zheng F., Chaudry I. H. Endothelium‐dependent relaxation is depressed at the macro‐ and micro‐circulatory levels during sepsis. Am J Physiol 1995; 269: R988–94
   PubMedGoogle Scholar
• Sun J., Xin C., Eu J. P., Stamler J. S., Meissner G. Cysteine 3635 is responsible for skeletal muscle ryanodine receptor modulation by NO. Proc Natl Acad Sci 2001; 98: 11158–62
   PubMed Web of Science ®Google Scholar
• Schmidt H. H. H. W., Walter U. NO at work. Cell 1994; 78: 919–25
   PubMed Web of Science ®Google Scholar
• Ignarro L. J. Biological actions and properties of endothelium‐derived nitric oxide formed and released from artery and veins. Circ Res 1989; 65: 1–21
   PubMed Web of Science ®Google Scholar
• Ignarro L. J. Introduction and overview. Nitric oxide: biology and pathobiology., L. J Ignarro. Academic Press, San Diego 2000; 3–19
   Google Scholar
• Salvemini D., Misko T. P., Masferrer J. L., et al. Nitric oxide activated cycloxygenase enzymes. Proc Natl Acad Sci 1993; 90: 7240–4
   PubMed Web of Science ®Google Scholar
• Fukoto J. M., Wallace G. C., Hszieh R., Chandhuri G. Chemical oxidation of N‐hydroxyguanidine compounds. Release of nitric oxide, nitroxyl and possible relationship to the mechanism of biological nitric oxide generation. Biochem Pharmacol 1992b; 43: 607–13
   PubMedGoogle Scholar
• Murad F. The nitric oxide‐cyclic GMP signal transduction system for intracellular and intercellular communication. Rec Prog Horm Res 1994; 49: 239–48
   PubMedGoogle Scholar
• Boveris A., Poderoso J. J. Regulation of oxygen metabolism by nitric oxide. Nitric oxide: biology and pathobiology., L. J Ignarro. Academic Press, San Diego 2000; 355–68
   Google Scholar
• Khatsenko O. G., Gross S. S., Rifkind A. B., Vane J. R. Nitric oxide is a mediator of the decrease in cytochrome P450‐dependent metabolism caused by immunostimulants. Proc Natl Acad Sci 1993; 90: 11147–51
   PubMed Web of Science ®Google Scholar
• Thomas S. R., Mohr D., Stocker R. Nitric oxide inhibits indolamine 2, 3‐dioxygenase activity in interferon‐primed mononuclear phagocytes. J Biol Chem 1994; 269: 14457–64
   PubMed Web of Science ®Google Scholar
• Molina J., Vedia L., MacDonald B. R., Reep B., et al. Nitric oxide‐induced s‐nitrosylation of glyceraldehyde‐3‐phosphate dehydrogenase inhibits enzymatic activity and increases endogenous ADP‐ribosylation. J Biol Chem 1992; 267: 24929–32
   PubMed Web of Science ®Google Scholar
• Zhang J., Snyder S. H. Nitric oxide stimulates auto‐ADP‐ribosylation of glyceraldehyde‐3‐phosphate dehydrogenase. Proc Natl Acad Sci 1992; 89: 9382–5
   PubMed Web of Science ®Google Scholar
• Gopalakrishna R., Hai Chen Z., Gundimeda U. Nitric oxide and nitric‐oxide generating agents induce a reversible inactivation of protein kinase C activity and phorbol ester binding. J Biol Chem 1993; 268: 27180–5
   PubMed Web of Science ®Google Scholar
• Stamler J. S. S‐nitrosothiols and bioregulatory actions of nitrogen oxides through reactions with thiol groups. Curr Top Microbiol Immunol 1995; 196: 19–36
   PubMedGoogle Scholar
• Laval F., Wink D. A. Inhibition by nitric oxide of the repair protein, O6‐DNA‐methyltransferase. Carcinogenesis 1994; 15: 443–7
   PubMed Web of Science ®Google Scholar
• Melino G., Bernassola F., Knight R. A., et al. S‐nitrosylation regulates apoptosis. Nature 1997; 388: 432–3
   PubMed Web of Science ®Google Scholar
• Asahi M., Fujii J., Suzuki K., et al. Inactivation of glutathione peroxidase by nitric oxide. Implication for cytotoxicity. J Biol Chem 1995; 270: 21035–9
   PubMed Web of Science ®Google Scholar
• Stamler J. S., Simon D. I., Jaraki O., et al. S‐nitrosylation of tissue‐type plasminogen activator confers vasodilatory and antiplatelet properties on the enzyme. Proc Natl Acad Sci 1992; 89: 8087–91
   PubMedGoogle Scholar
• Stamler J. S., Jaraki O., Osborne J., et al. Nitric oxide circulates in mammalian plasma primarily as an s‐nitroso adduct of serum albumin. Proc Natl Acad Sci 1992; 89: 7674–7
   PubMed Web of Science ®Google Scholar
• Stamler J. S., Simon D. I., Osborne J. A., et al. S‐nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc Natl Acad Sci 1992; 89: 444–8
   PubMed Web of Science ®Google Scholar
• Singh S. P., Wishnok J. S., Keshive M., Deen W. M., Tannenbaum S. R. The chemistry of the s‐nitroso‐glutathione/glutathione system. Proc Natl Acad Sci 1996; 93: 14428–33
   PubMed Web of Science ®Google Scholar
• Ji Y., Akerboom T. P. M., Sies H., Thomas J. A. S‐Nitrosylation and S‐glutathionylation of protein sulfhydryls by S‐nitroso glutathione. Arch Biochem Biophys 1999; 362: 67–78
   PubMed Web of Science ®Google Scholar
• Hausladen A., Fridovichi I. Superoxide and peroxynitrite inactivate aconitases, but nitric oxide does not. J Biol Chem 1994; 269: 29405–8
   PubMed Web of Science ®Google Scholar
• Radi R., Rodriguez M., Castro L., Telleri R. Inhibition of mitochondrial electron transport by peroxynitrite. Arch Biochem Biophys 1994; 308: 89–95
   PubMed Web of Science ®Google Scholar
• Scott M., Meshnik S., Eaton J. Superoxide dismutase‐rich bacteria. Paradoxical increase in oxidant toxicity. J Biol Chem 1987; 262: 3640–5
   PubMed Web of Science ®Google Scholar
• Bloch C., Ausubel F. Paraquat‐mediated selection for mutations in the manganese‐superoxide dismutase gene sodA. J Bacteriol 1986; 168: 795–8
   PubMed Web of Science ®Google Scholar
• Amstad P., Peskin A., Shah G., et al. Paraquat‐mediated selection for mutations in the manganese‐superoxide dismutase gene sodA. Biochemistry 1991; 30: 9305–13
   PubMed Web of Science ®Google Scholar
• Mao G., Thomas P., Lopaschuk G., Poznansky M. Superoxide dismutase (SOD)‐catalase conjugates. Role of hydrogen peroxide and the Fenton reaction in SOD toxicity. J Biol Chem 1993; 268: 416–20
   PubMed Web of Science ®Google Scholar
• Amstad P., Moret R., Cerutti P. Glutathione peroxidase compensates for the hypersensitivity of Cu, Zn superoxide dismutase overproducers to oxidant stress. J Biol Chem 1994; 269: 1606–9
   PubMed Web of Science ®Google Scholar
• Kelner M., Bagnell R. Alteration of endogenous glutathione peroxidase, manganese superoxide dismutase, and glutathione transferase activity in cells transfected with a copper‐zinc superoxide dismutase expression vector. Explanation for variations in paraquat resistance. J Biol Chem 1990; 265: 10872–95
   PubMed Web of Science ®Google Scholar
• Staver P. J. Physiology of folate and vitamin B12 in health and disease. Nutr Rev 2004; 62: S3
   PubMedGoogle Scholar
• Mannervik B., Widersten M., Board P. G. Glutathione‐linked enzymes in detoxication reactions. Glutathione centennial, molecular perspectives and clinical implications., N Tamiguchi, T Higashi, Y Sakanoto, A Meister. Academic Press, New York 1989; 23–34
   Google Scholar
• Mannervik B., Carlberg I., Larson K. Glutathione: General Review of Mechanism of Action. Glutathione chemical, biochemical and medical aspects, coenzymes and cofactors, D Dolphin, O Avramovic, R Poulson. Wiley, New York 1989; 3A: 476–517
   Google Scholar
• Wink D. A., Cook J. A., Kim S. Y., et al. Superoxide modulates the oxidation and nitrosation of thiols by nitric oxide‐derived reactive intermediates. Chemical aspects involved in the balance between oxidative and nitrosative stress. J Biol Chem 1997; 272: 11147–51
   PubMed Web of Science ®Google Scholar
• Brigelius R. Mixed disulfides: biological functions and increase in oxidative stress. Oxidative stress., H Sies. Academic Press, London 1985; 243–72
   Google Scholar
• Hamilos D. L., Wedner H. J. The role of glutathione in lymphocyte activation. I. Comparison of inhibitory effects of buthionine sulfoximine and 2‐cyclohexene‐1‐one by nuclear size transformation. J Immunol 1985; 135: 2740–7
   PubMed Web of Science ®Google Scholar
• Ling C. T., Chow B. F. Effect of vitamin B12 on the levels of soluble sulfhydryl compounds in blood. J Biol Chem 1953; 202: 445–56
   PubMedGoogle Scholar
• Register U. D. The effect of vitamin B12 on liver and blood non‐protein sulfhydryl compounds. J Biol Chem 1954; 206: 705–9
   PubMedGoogle Scholar
• Dubnoff J. W., Bartron E. The effect of B12 on enzyme activity in E. coli mutant 113‐3. Arch Biochem Biophys 1956; 61: 99–110
   PubMedGoogle Scholar
• Peel J. L. Vitamin B12 derivatives and the CO2‐pyruvate exchange reaction: a reappraisal. J Biol Chem 1962; 237: PC263–5
   PubMedGoogle Scholar
• Aronovitch J., Grossowicz N. Cobalamin catalyzed oxidation of sulfhydryl groups. Biochem Biophys Res Comm 1962; 8: 416–20
   PubMedGoogle Scholar
• Schrauzer G. N., Windgassen R. J. On cobaloximes with cobalt‐sulfur bonds and some model studies related to cobamide‐dependent methyl‐group‐transfer reactions. J Am Chem Soc 1967; 89: 3607
   Google Scholar
• Jacobsen D. W., Pezacka E. H., Brown K. L. The inhibition of corrinoid‐catalyzed oxidation of mercaptoethanol by methyl iodide: mechanistic implications. J Inorg Biochem 1993; 50: 47–63
   PubMedGoogle Scholar
• Kuo P., Abe K. Y., Schroeder R. A. Interleukin‐I‐induced nitric oxide production modulates glutathione synthesis in cultured rat hepatocytes. Am J Physiol 1996; 271: C851–62
   PubMed Web of Science ®Google Scholar
• Kharitonov V. G., Sundquist A. R., Sharma V. S. Kinetics of nitrosation of thiols by nitric oxide in the presence of oxygen. J Biol Chem 1995; 270: 28158–64
   PubMed Web of Science ®Google Scholar
• Clementi E., Brown G. C., Feelisch M., Moncada S. Persistent inhibition of cell respiration by nitric oxide: crucial role of S‐nitrosylation of mitochondrial complex I and protective action of glutathione. Proc Natl Acad Sci 1998; 95: 7631–6
   PubMed Web of Science ®Google Scholar
• Arteel G. E., Briviba K., Sies H. Mechanisms of antioxidant defense against nitric oxide/peroxynitrite. Nitric oxide: biology and pathobiology., L. J Ignarro. Academic Press, San Diego 2000; 343–54
   Google Scholar
• Quijano C., Alvarez B., Gatti R. M., Angusto O., Radi R. Pathways of peroxynitrite oxidation of thiol groups. Biochem J 1997; 322: 167–73
   PubMed Web of Science ®Google Scholar
• Morris S. L., Walsh R. C., Hauser J. N. Identification and characterization of some bacterial membrane sulfhydryl groups which are targets of bacteriostatic and antibiotic action. J Biol Chem 1984; 259: 13590–4
   PubMed Web of Science ®Google Scholar
• Gilbert H. S. Proposal of a possible function for granulocyte vitamin B12 binding proteins in host defense against bacteria. Blood 1974; 44: 926
   Web of Science ®Google Scholar